Building a shared AL vs. ATTR diagnostic pathway

Listen to our expert faculty explore a shared diagnostic pathway for cardiac amyloidosis, including clinical and imaging red flags, monoclonal-protein testing, and the role of biopsy and amyloid typing. They also explore multidisciplinary collaboration and when to prioritize ruling out amyloid light-chain amyloidosis (AL).

The multidisciplinary team:

• Cardiologist – Dr. Christian Nitsche, Medical University of Vienna, Vienna, Austria
• Hematologist – Dr. Yawara Kawano, Kumamoto University Hospital, Kumamoto City, Japan
• Amyloidosis specialist with a renal focus – Dr. Paolo Milani, University of Pavia, Pavia, Italy 

This touchPODCAST is for healthcare professionals outside of the UK.

This activity is supported by an independent medical education grant from Alexion Pharma GmbH.

Jointly provided by Partners for Advancing Clinical Education and touchIME. touchIME is an EBAC® accredited provider.

For further information, please visit our websites: touchHEMATOLOGY, touchCARDIO and touchNEPHROLOGY